A Phase I Study of Apolizumab, an Anti-HLA-DR ß-chain Monoclonal Antibody, in Patients With Solid Tumor Malignancies.
- Resource Type
- Article
- Source
- American Journal of Clinical Oncology; Jul2022, Vol. 45 Issue 7, p294-297, 4p
- Subject
- Language
- ISSN
- 02773732